EXELA PHARMA SCIENCES

Lobbying Spend

—

Filings

Firms Hired

Active Period

2017–2024

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2024	—	3	1
2023	—	4	1
2022	—	4	1
2021	—	8	2
2020	—	8	2
2019	—	4	1
2018	—	5	1
2017	—	1	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FIDELIS GOVERNMENT RELATIONS	—	8
BROYDRICK & ASSOCIATES	—	29

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	21
SENATE	21
Food & Drug Administration (FDA)	13
Health & Human Services, Dept of (HHS)	7
Centers For Disease Control & Prevention (CDC)	4
President of the U.S.	4

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	15
Health Issues	Health Issues	8

EXELA PHARMA SCIENCES — Lobbying Disclosure | Poliscope